In Mao et al. (2014) the electro-acupuncture group (n = 22) showed significant improvements compared to the sham group (n = 22), including woman with a history of breast cancer under aromatase inhibitor therapy over 2, 4 and 8 weeks. The gene discussed is CYP19A1; the disease is breast cancer.